Cargando…

Increased SPHK1 and HAS2 Expressions Correlate to Poor Prognosis in Pancreatic Cancer

OBJECTIVE: SPHK1 and HAS2 have been reported to play important roles in tumorigenesis and development. However, their expression and prognostic value in pancreatic cancer (PC) remain unclear. This study is aimed at investigating the expression of SPHK1 and HAS2 on the prognosis of pancreatic cancer....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Mengsi, Zhang, Kainan, Wang, Song, Xue, Li, Chen, Zhaoyun, Feng, Ning, Ning, Conghua, Wang, Lijuan, Li, Jing, Zhang, Boke, Yang, Changcheng, Zhang, Zhaoxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806397/ https://www.ncbi.nlm.nih.gov/pubmed/33506044 http://dx.doi.org/10.1155/2021/8861766

Ejemplares similares

Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma
por: Zhang, Kainan, et al.
Publicado: (2022)

Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma
por: Chen, Ming-Huang, et al.
Publicado: (2015)

Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma
por: Bao, Ji-Ming, et al.
Publicado: (2023)

CEACAM1 Is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Clear Cell Renal Cell Carcinoma
por: Yang, Lu, et al.
Publicado: (2023)

Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo
por: Xun, Cai, et al.
Publicado: (2015)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
por: Lu, Lingling, et al.
Publicado: (2022)

Long noncoding RNA OR3A4 promotes the proliferation and invasion of osteosarcoma cells by sponging miR-1227-5p
por: Yang, Changcheng, et al.
Publicado: (2020)

Identification of Upregulated HNRNPs Associated with Poor Prognosis in Pancreatic Cancer
por: Qiao, Lu, et al.
Publicado: (2019)

Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
por: Hatoum, Diana, et al.
Publicado: (2017)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
por: Bu, Yanhong, et al.
Publicado: (2021)

Sphk1 and Sphk2 Differentially Regulate Erythropoietin Synthesis in Mouse Renal Interstitial Fibroblast-like Cells
por: Hafizi, Redona, et al.
Publicado: (2022)

Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer
por: Zhao, Qiaoyun, et al.
Publicado: (2021)

Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer
por: Wang, Shujie, et al.
Publicado: (2021)

Design, Synthesis and Biological Activity Testing of Library of Sphk1 Inhibitors
por: Geng, Shuangshuang, et al.
Publicado: (2022)

High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer
por: He, Yun, et al.
Publicado: (2016)

MicroRNA-338-3p Suppresses Proliferation of Human Liver Cancer Cells by Targeting SphK2
por: Xiao, Geqiong, et al.
Publicado: (2018)

ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis
por: Yan, Qiang, et al.
Publicado: (2021)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015)

Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma
por: Shi, Weiwei, et al.
Publicado: (2020)

CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration
por: Zhang, Ronghua, et al.
Publicado: (2020)

High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma
por: Huang, Jianfei, et al.
Publicado: (2015)

Expression of SIRT1 and survivin correlates with poor prognosis in esophageal squamous cell carcinoma
por: Yan, Li, et al.
Publicado: (2020)

DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jianyu, et al.
Publicado: (2019)

High RRM2 expression has poor prognosis in specific types of breast cancer
por: Shi, Shen-chao, et al.
Publicado: (2022)

TOP2A correlates with poor prognosis and affects radioresistance of medulloblastoma
por: Zhang, Yufeng, et al.
Publicado: (2022)

Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
por: Sun, Bing‐sheng, et al.
Publicado: (2016)

Overexpression of thymic stromal lymphopoietin is correlated with poor prognosis in epithelial ovarian carcinoma
por: Xu, Lu, et al.
Publicado: (2019)

Increased Serum Level of MicroRNA-663 Is Correlated with Poor Prognosis of Patients with Nasopharyngeal Carcinoma
por: Liang, Shaoqiang, et al.
Publicado: (2016)

An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma
por: Pan, Jian, et al.
Publicado: (2011)

High expression of TROP2 correlates with poor prognosis in pancreatic cancer
por: Fong, D, et al.
Publicado: (2008)

SGK3 overexpression correlates with a poor prognosis in endoscopically resected superficial esophageal squamous cell neoplasia: A long-term study
por: Xu, Ning, et al.
Publicado: (2023)

Dynamin 2 Is Correlated with Recurrence and Poor Prognosis of Papillary Thyroid Cancer
por: Ren, Ning, et al.
Publicado: (2020)

A personalized mRNA vaccine has exhibited potential in the treatment of pancreatic cancer
por: Kang, Ning, et al.
Publicado: (2023)

Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR/SphK1 crosstalk
por: Schiefler, Carlotta, et al.
Publicado: (2014)

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
por: Zhang, Luan-Jing, et al.
Publicado: (2014)

SphK2 over-expression promotes osteosarcoma cell growth
por: Xu, Dawei, et al.
Publicado: (2017)

Low SOX12 Expression Is Correlated With Poor Prognosis in Patients With Gastric Cancer
por: Yang, Kan-kan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mvhm1gevrgvu8j3tup5r1q78s4